Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class ASSE: 600436

Announcement on Completion of First Participant Enrollment in the Phase III Clinical Trial of Changji’an Capsules

· Issued by Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Completion of First Participant Enrollment in the Phase III Clinical Trial of Changji’an Capsules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A

All Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A news releases